Results 51 to 60 of about 24,903 (156)

Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges. [PDF]

Anal Chem
Kumar S, Tini A, Tengattini S, Rinaldi F, Calleri E, Massolini G, Temporini C.   +6 more
europepmc   +1 more source

Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseases. [PDF]

Proc Natl Acad Sci U S A
Sanmarco LM, Pellerin A, Green T, Plasencia A, Anderson JM, Le N, Newton A, Chen J, Ramello MC, Peckner R, Manasson J, Xing Y, Vital H, Higginson-Scott N, Sundy JS, Otipoby KL, Mascanfroni ID.   +16 more
europepmc   +1 more source

Simultaneous quantification of anti-Spike IgG subclasses against various SARS-CoV-2 variants using a multiplex serological assay. [PDF]

Med Microbiol Immunol
Bischof ML, Irrgang P, Tenbusch M, Keppler OT, Wratil PR.   +4 more
europepmc   +1 more source

Toward site-specific characterization of structural perturbations on glycosylated Fc using NMR at natural abundance. [PDF]

J Biomol NMR
Vibert B, Nguyen S, Henot F, Doyen C, Hernandez-Alba O, Cianférani S, Clavier S, Frances O, Boisbouvier J.   +8 more
europepmc   +1 more source

Unlabeled NMR Approach with Site-Specific Methyl Assignments for Structural Evaluation of the IgG1 Fc Region. [PDF]

J Am Chem Soc
Yanaka S, Koseki Y, Miyanoiri Y, Yamazaki T, Terauchi T, Kaneko D, Isono Y, Tomita K, Kondo S, Onitsuka M, Yagi-Utsumi M, Yagi H, Ishii-Watabe A, Kato K.   +13 more
europepmc   +1 more source

Immunoglobulin G complexes from post-infectious ME/CFS, including post-COVID ME/CFS disrupt cellular energetics and alter inflammatory marker secretion. [PDF]

Brain Behav Immun Health
Liu Z, Hollmann C, Kalanidhi S, Lamer S, Schlosser A, Basens EE, Nikolayshvili G, Sokolovska L, Riemekasten G, Rust R, Bellmann-Strobl J, Paul F, Naviaux RK, Nora-Krukle Z, Sotzny F, Scheibenbogen C, Prusty BK.   +16 more
europepmc   +1 more source

The Amino Acid Sequence of the Fc Fragment of Rabbit Immunoglobulin G

Journal of Biological Chemistry, 1968
R Delaney, R L Hill
openaire   +2 more sources

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]

Blood Neoplasia
Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.   +29 more
europepmc   +1 more source

A recombinant IgG1 Fc-domain protein ameliorates inflammatory demyelinating peripheral neuropathy. [PDF]

Front Immunol
Otlu HG, Gao T, Coffey GP, Bright JM, Toda AMA, Conley PB, Sheikh K, Zhang G.   +7 more
europepmc   +1 more source

Enhancing IgG fragment crystallizable sialylation improves the therapeutic activity of IL-23 cytokine blockade. [PDF]

JCI Insight
Kämpf S, Hematianlarki M, Altmann L, Bright JM, Toda AM, Mirzapoor Z, Zollner V, Werner A, Bulang J, Radovani B, Wöhner M, Avery W, Karbarz MJ, Conley PB, Coffey GP, Nimmerjahn F.   +15 more
europepmc   +1 more source